Oncohost

Personalized cancer therapy

Cancer, Healthcare, Oncology
Machine Learning

Business Overview

OncoHost is a newly established company developing personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand the patient’s unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to therapy.

Operating Status
Active
Founded
June 2017
Employees
12
Business model
B2B
Offering type
Software
Funding stage
Series B
Total funding
$8 Million
Sectors
Cancer, Healthcare, Oncology, Pharmaceutical

Funding Rounds

New wpDataTable

Date Announced

Funding Round

Amount Raised

Investors

January 2021
Series B
$8 M
January 2020
Grant

AI Technology Stack

AI Description

OncoHost’s technology is based on machine learning generated analysis of the pro-tumorigenic processes induced by the body’s response to cancer treatments. We discover new targets that may be combined with current, standard-of-care, treatments to increase responsiveness.

AI employees
4
AI application
Vertical AI
AI types
Machine Learning

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events